The key role of differential broad H3K4me3 and H3K4ac domains in breast cancer

Keyphrases

• Breast Cancer 100%
• Broad H3K4me3 Domains 100%
• H3K4ac 100%
• Cancer Cells 50%
• Identified Genes 33%
• Histone H3 33%
• H3K4me3 33%
• Histone Post-translational Modifications 33%
• Coding Region 16%
• Cell Properties 16%
• Epigenetic Mechanisms 16%
• In Cancer 16%
• MCF-7 16%
• Chromatin Immunoprecipitation (ChIP) 16%
• Breast Cancer Treatment 16%
• Cancer Genes 16%
• Small Populations 16%
• Lysine 16%
• Two-peak 16%
• Therapeutic Treatment 16%
• Sequence Data 16%
• Gene Expression Programming 16%
• Transcription Start Site 16%
• Chromatin Remodelers 16%
• Triple-negative Breast Cancer 16%
• 5′-end 16%
• Cell Identity 16%
• Transcriptionally Active 16%
• Breast Cancer Subtypes 16%
• Luminal Breast Cancer 16%
• Chromatin-modifying Enzymes 16%
• Broad Domains 16%
• MDA-MB-231 Cancer Cells 16%
• MCF10A 16%
• Genomic Distribution 16%
• Epigenetic Events 16%
• Acetylated Lysine 16%
• Peak-caller 16%
• Domain Configuration 16%
• DNA Modification 16%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Epigenetics 66%
• Histone H3 66%
• Posttranslational Modification 66%
• Histone 66%
• Lysine 66%
• Enhancer Region 33%
• Promoter Region 33%
• Coding Region 33%
• Enzyme 33%
• Chromatin Immunoprecipitation 33%
• Preclinical Study 33%
• Transcription Initiation Site 33%
• Tumor-Related Gene 33%
• DNA Modification 33%
• Genomics 33%